Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH
This study is not yet open for participant recruitment.
Verified by Hadassah Medical Organization, February 2006
Sponsors and Collaborators: Hadassah Medical Organization
Shaare Zedek Medical Center
Information provided by: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT00405626
  Purpose

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana


Condition Intervention Phase
Hemorrhage
Drug: Bellis Perenis ,Arnica montana
Phase I

Drug Information available for: Arnica extract
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Phase 2 Study of the Effect of Bellis Perenis and Arnica Montana on Post Partum Hemmorhage

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • hemoglobin levels 2 days post partum

Secondary Outcome Measures:
  • pain

Estimated Enrollment: 210
Study Start Date: April 2007
Estimated Study Completion Date: September 2007
Detailed Description:

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana compare it with placebo

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy women during delivery

Exclusion Criteria:

  • Scarred uterus, multifetal ,multiparty,bleeding problems,cesarean sectons,chorioamnionitis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00405626

Contacts
Contact: David Mankuta, MD 5791070 mankuta@yahoo.com
Contact: Menachem Oberbaum, MD

Locations
Israel
Haddasah Medical Organization
JERUSALEM, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Shaare Zedek Medical Center
Investigators
Study Chair: David Mankuta Hadassah University Medical Organization
  More Information

Publications of Results:
Study ID Numbers: Hompostpartum-HMO-CTIL
Study First Received: November 29, 2006
Last Updated: November 29, 2006
ClinicalTrials.gov Identifier: NCT00405626  
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
post partum hemmorhage,Arnica montana,Bellis Perenis

Study placed in the following topic categories:
Hemorrhage

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on January 14, 2009